MDxHealth has presented results from two studies of its DNA methylation-based assay at the ASCO Genitourinary Cancers Symposium 2013, held at Orlando, Florida, US from 14 - 16 February 2013. The epigenetic assay, ConfirmMDx for Prostate ...
Albany Molecular Research (AMRI) and Chai Therapeutics, an affiliate of Bessor Pharma, have signed a licensing deal to develop tubulin inhibitor compound, ALB 109564(a), for cancer treatment. AMRI's ALB 109564(a) is a novel analog ...
Applying the same technologies used for voice recognition and credit card fraud detection to medical treatments could cut healthcare costs and improve patient outcomes by almost 50%, according to new research. The research by Indiana ...
Tags: medical treatments, healthcare costs, simulation modeling
MolecularMD has obtained an exclusive license to LKB1 for diagnostic, prognostic and predictive uses in non-small cell lung cancer patients. The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North ...
Epic Sciences, a developer of diagnostic tests, has received a Phase II small business innovation research (SBIR) contract from the National Cancer Institute (NCI) and the National Institutes of Health (NIH) for the development of a lung ...
Tags: lung cancer diagnostic, blood test, Epic
The National Cancer Institute (NCI) and the National Institutes of Health (NIH) have announced a Phase II small business innovation research (SBIR) contract to Epic Sciences for the development of a lung cancer diagnostic blood test. The ...
Cancer patients in the north-east of England will be able to receive modern radiosurgery treatments without having to travel outside the region since the Northern Centre for Cancer Care (NCCC) in Newcastle –upon-Tyne announced that it ...
Tags: Cancer patients, NCCC, TrueBeam STx, medical linear accelerators
A new cancer research and treatment facility is aiming to improve outcomes for thousands of people with cancer in the UK. The integrated laboratory is the first of its kind in Britain and Ireland and is based at Queen's University ...
Tags: cancer research, treatment facility, UK
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
Provectus Pharmaceuticals has announced the commencement of Phase 1 study of PV-10 injection to elucidate bystander effect at the Moffitt Cancer Center. The study is designed to assess the possible immune biomarkers in both tumor tissue ...
Tags: Provectus, injection, immune biomarkers, PV 10 injection
Volition has announced a new collaboration with the Wales Cancer Bank,with the two businesses set to carry out an internal clinical study for the Nucleosomics diagnostic products. At the end of this month,tests will be carried out on ...
Tags: Volition, Wales Cancer Bank, Nucleosomics diagnostic products
The analysis of DNA mutations in patients with cancer can be carried out without surgery. This is according to new research from AACC's Clinical Chemistry journal, which demonstrated that the plasma of cancer patients also includes ...
Tags: DNA mutations, cancer, surgery, Clinical Chemistry
Ribbons Express Sponsors Event to Complete Purchase of "Johnny's House," A Home for Cancer Respite Patients CHERRY HILL, NJ, September 26, 2012 /24-7PressRelease/ -- The Johnny M Foundation , an organization dedicated to improving the ...
Tags: Fundraising Gala, Computer Products, Johnny M Foundation
ApoCell will present the study abstracts of its circulating tumor cells (CTC) recovery technology at the Molecular Targets and Cancer Therapeutics Conference, which will be held in Dublin, Ireland from 6-9 November 2012. Using a ...
Tags: CTC Recovery Technology, medical study, medical technology
US medical center, Mayo Clinic, has signed a pre-clinical research agreement with MagForce. Under the agreement, Mayo Clinic will begin a research program to investigate the preclinical efficacy of the MagForce's NanoTherm therapy in ...